Wolverine Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wolverine Trading’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-209	Closed	-$9K	–	6733
2021 Q4	$9K	Buy	+209	New	+$13K	﹤0.01%	5544
2019 Q3	–	Sell	-245	Closed	-$22K	–	5204
2019 Q2	$22K	Sell	245 -49	-17%	-$5.96K	﹤0.01%	4283
2019 Q1	$43K	Buy	294 +120	+69%	+$23.2K	﹤0.01%	4338
2018 Q4	$26K	Sell	174 -196	-53%	-$37.6K	﹤0.01%	4258
2018 Q3	$91K	Buy	370 +38	+11%	+$9K	﹤0.01%	4570
2018 Q2	$81K	Hold	332	–	–	﹤0.01%	4794
2018 Q1	$81K	Sell	332 -300	-47%	-$78.7K	﹤0.01%	4794
2017 Q4	$195K	Buy	632 +281	+80%	+$92.4K	﹤0.01%	4180
2017 Q3	$129K	Buy	+351	New	+$125K	﹤0.01%	3989
2017 Q1	–	Sell	-191	Closed	-$48.2K	–	5206
2016 Q4	$42K	Buy	+191	New	+$38.3K	﹤0.01%	4241

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wolverine Trading's DMK Position: Q1 2022 in Review

Wolverine Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2022, closing a stake of 209 shares — an estimated $9K sold.

Wolverine Trading first reported a position in DMK in Q4 2016 and held it in 10 quarters. The position peaked at $195K in Q4 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

Wolverine Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
Wolverine Trading sold 209 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2022, an estimated $9K.
Wolverine Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 10 quarters.
Wolverine Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $195K in Q4 2017.
46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.